ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,060, issued on April 22, was assigned to Washington University (St. Louis).

"Methods of treating cancer using neuronal activity inhibiting agents" was invented by David Gutmann (St. Louis) and Corina Anastasaki (St. Louis).

According to the abstract* released by the U.S. Patent & Trademark Office: "Among the various aspects of the present disclosure is the provision of methods for inhibiting neuronal activity in NF1 tumors. One aspect of the disclosure provides for a method of inhibiting tumor growth comprising administering a neuronal activity inhibiting agent to a subject in need thereof. Another aspect of the disclosure provides for a method of attenuating neuronal excitability...